Otcbb, Pink Sheet, Nasdaq, Nyse, and AMEX traded hot penny stocks to find our readers the most relevant Hot Penny Stocks. Please visit our site frequently as we are continuously adding new hot penny stock profiles.   We provide merchant banking services, and reverse mergers to management teams and corporations interested in long- term success, and integrity. Venture Capital Partners acts as a primary consultant or deal sponsor and is responsible for all of the corporate finance activities. We will arrange the financing, advise on acquisitions, help recruit management, coordinate the legal and accounting advisors, select underwriters, and provide ongoing strategic advice through board representation.


Home  Financing   Profiled   Otcbb News   About Us   Trading Myths   Pink Sheets   Links   Contact

Penny Stocks
Penny Stock archives

Disclaimer

PennyMarkets.com information should not be construed as investment advice. PennyMarkets.com and its affiliates are not investment advisors. Penny Stocks are risky investments, and investors can lose all of their investment. Before making any investment decision please consult an investment advisor. Here is a link to several investment advisors!

Friday, April 29, 2005

 

Penny Stocks NEOP Neoprobe Announces First Quarter Results; First Quarter Device Sales Increase 20% Over Prior Year; Business Update

NEOP Neoprobe Announces First Quarter Results; First Quarter Device Sales Increase 20% Over Prior Year; Business Update Provided and Conference Call Scheduled: "NEOP Neoprobe Announces First Quarter Results; First Quarter Device Sales Increase 20% Over Prior Year; Business Update Provided and Conference Call Scheduled

DUBLIN, Ohio--(BUSINESS WIRE)--April 28, 2005--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced consolidated operating results for the first quarter of 2005. First quarter results included net sales of devices of $1.5 million compared to $1.2 million for the first quarter of 2004. In addition, Neoprobe reported a net loss of $1 million or $0.02 per share compared to a loss of $589,000 or $0.01 per share for the comparable period in 2004. The net loss for the first quarter of 2005 included $453,000 in non-cash charges consisting primarily of interest and other charges related to the financing that was completed in December 2004 compared to total non-cash charges of $205,000 for the first quarter of 2004.


Brent Larson, Neoprobe's Vice President, Finance & CFO, said, 'Our first quarter device sales improved compared to the prior year due primarily to a slight strengthening in gamma device prices and increased extended service contract sales activity through our primary gamma device marketing partner. The improvement in sales prices and increased extended service contract sales, coupled with the impact of design improvements to our neo2000(R) gamma device line completed in early 2004, contributed to an overall increase in gross margins on device sales to 62% of net sales compared to 56% of net sales in the prior year.'
"
Otcbb News and Informatuion About the OTCBB trading platform, and listing information.

Penny Stocks Trading Information Learn about how penny stocks generally trade, and how to avoid the big mistake.

Pink Sheets Listing, and Trading Information Learn about the Pink Sheets, and how they can help your company move forward.

NEOP Information, Stock Tips, Stock Picks, Investing Online, Day TradingNews, Charts, and More on NEOP


This page is powered by Blogger. Isn't yours?



Penny Stocks   Financing   Profiled   Otcbb Info   About Penny Stocks    Penny Stock Trading Myths   Pink Sheets   Penny Stock L inks   Contact